Leading science, pioneering therapies

CRM Publications

Found 8 results
Filters: Keyword is Liver Cirrhosis  [Clear All Filters]
2014
Williams MJ, Clouston AD, Forbes SJ.  2014.  Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion.Gastroenterology. 146(2):349-56.
Fallowfield JA, Hayden AL, Snowdon VK, Aucott RL, Stutchfield BM, Mole DJ, Pellicoro A, Gordon-Walker TT, Henke A, Schrader J et al..  2014.  Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo.Hepatology. 59(4):1492-504.
2012
Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, Hartland SN, Snowdon VK, Cappon A, Gordon-Walker TT et al..  2012.  Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis.Proc Natl Acad Sci U S A. 109(46):E3186-95.
Forbes SJ, Newsome PN.  2012.  New horizons for stem cell therapy in liver disease.J Hepatol. 56(2):496-9.
2011
Forbes SJ, Parola M.  2011.  Liver fibrogenic cells.Best Pract Res Clin Gastroenterol. 25(2):207-17.
Thomas JA, Pope C, Wojtacha D, Robson AJ, Gordon-Walker TT, Hartland SN, Ramachandran P, Van Deemter M, Hume DA, Iredale JP et al..  2011.  Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.Hepatology. 53(6):2003-15.
2008
Henderson NC, Forbes SJ.  2008.  Hepatic fibrogenesis: from within and outwith.Toxicology. 254(3):130-5.
Lorenzini S, Isidori A, Catani L, Gramenzi A, Talarico S, Bonifazi F, Giudice V, Conte R, Baccarani M, Bernardi M et al..  2008.  Stem cell mobilization and collection in patients with liver cirrhosis.Aliment Pharmacol Ther. 27(10):932-9.